Vanessa's Comment:

Interim results from this trial were shared at the SNO 2023 annual meeting (see here). We look forward to seeing final results when they get published!


Posted on: 04/22/2024

ROSALIE Trial of EO2401/Nivolumab/Bevacizumab in Recurrent Glioblastoma Concludes

 


Click HERE to return to brain tumor news headlines.


Our privacy / cookie policy has changed.
Click HERE to read it!